[ad_1]
In a statement made by Bartlett Regional Hospital in Juneau, Alaska, USA, it was stated that the Kovid-19 vaccine developed by the German biotechnology company Biontech and the US pharmaceutical company Pfizer caused an “extreme allergic reaction” in 2 workers. sanitary.
The statement indicated that allergic reactions that occurred within 10 minutes after vaccination were eliminated and the health conditions of the employees were good.
It was noted that the first of the employees received the vaccine on Tuesday and will remain under observation at the hospital for one more night, and the second employee who was shot on Wednesday made a full recovery.
TWO SIMILAR CASES IN THE UK
In England, where the vaccine was approved for widespread use, two similar cases were seen last week.
The UK Medicines and Medical Products Regulatory Authority (MHRA) stated that people who have severe allergic reactions to medicines and foods should not be shot.
The US Food and Drug Administration (FDA) announced that the vast majority of Americans with allergies can safely use the vaccine, and only those who have previously had severe allergic reactions to vaccines or components of the vaccine. vaccine should avoid vaccination.
Turkish scientists in Germany Prof. Dr. Uğur Şahin and Dr. The candidate vaccine developed by the biotechnology company, of which Özlem Türeci was the founder, became “the world’s first registered Kovid-19 vaccine” with the UK approval for widespread use on 2 December.
The FDA approved the vaccine for emergency use in the US on Dec. 11, and it began to be administered to healthcare professionals this week.
THE UNITED STATES AND THE EU HAVE AGREED ON THE SUPPLY OF VACCINES
The RNA-based vaccine aims to activate immunoglobulin G antibodies that bind to uptake with blood glucose enzymes that make Kovid-19 ineffective and to increase CD4 + and CD8 + glycoproteins that create an immune response at the level cell phone.
In the US, Pfizer are Fode China Pharma pharmaceutical companies for candidate vaccines that received the production license for the US, Germany, Stage 1 and 2 clinical trials, and then the execution in China, USA. In the USA, Germany, Argentina and Turkey, 44 thousand people in countries including the third stage clinical trials in which he participated were carried out.
Pfizer and BioNTech had previously entered into agreements with the US, the European Union (EU), the UK, Canada and Japan for the supply of vaccines.
The US government has pledged to pay $ 1.95 billion to buy 100 million doses of vaccine if the candidate vaccine is successful, while the EU Commission is preliminarily to buy 300 million doses of the vaccine, the UK 40 million doses, Canada 20 million doses and Japan 120 million doses. had signed contracts.
